Asset Allocation

As of January 31, 2026.
Type % Net
Cash 0.50%
Stock 58.41%
Bond 32.33%
Convertible 0.00%
Preferred 1.70%
Other 7.05%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 91.01%    % Emerging Markets: 0.31%    % Unidentified Markets: 8.69%

Americas 83.53%
83.45%
Canada 56.48%
United States 26.97%
0.08%
As of January 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 5.93%
United Kingdom 3.27%
2.66%
Denmark 0.16%
France 0.62%
Germany 0.78%
Netherlands 0.36%
Switzerland 0.41%
0.00%
0.00%
Greater Asia 1.86%
Japan 0.47%
0.06%
Australia 0.06%
1.14%
Hong Kong 0.22%
Singapore 0.04%
South Korea 0.68%
0.18%
China 0.18%
Unidentified Region 8.69%

Bond Credit Quality Exposure

AAA 14.05%
AA 5.35%
A 7.49%
BBB 20.89%
BB 30.96%
B 10.47%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.17%
Not Available 10.63%
Short Term 0.00%
As of January 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
42.74%
Materials
10.97%
Consumer Discretionary
4.38%
Financials
25.57%
Real Estate
1.82%
Sensitive
37.25%
Communication Services
4.01%
Energy
9.07%
Industrials
11.56%
Information Technology
12.61%
Defensive
7.74%
Consumer Staples
2.83%
Health Care
2.83%
Utilities
2.08%
Not Classified
12.26%
Non Classified Equity
2.80%
Not Classified - Non Equity
9.46%
As of January 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of January 31, 2026
Type % Net
Government 9.01%
Corporate 69.85%
Securitized 1.22%
Municipal 7.71%
Other 12.21%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.93%
Less than 1 Year
0.93%
Intermediate
66.10%
1 to 3 Years
5.44%
3 to 5 Years
20.78%
5 to 10 Years
39.88%
Long Term
27.96%
10 to 20 Years
7.28%
20 to 30 Years
11.29%
Over 30 Years
9.38%
Other
5.00%
As of January 31, 2026
View Bond Maturity Exposure
Start Trial